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Summary
Infection with Staphylococcus aureus and the productionoftoxic shock syndrome toxin-1 (TSST1)
have been implicated in the pathogenesis of toxic shock syndrome. Previous in vitro studies have
demonstrated that TSST1 is a powerful but selective stimulator of human T cells, and that the
majority of activated cells express the TCR V02 gene segment. We therefore studied patients
with toxic shock syndrome using a modification of the PCR to determine if expansion of V02+
T cells is a marker of the in vivo disease process. Five of eight patients studied demonstrated
markedly elevated levels of circulating V02+ T cells, whereas none showed significantly elevated
levels of T cells expressing other V/3 gene segments. The results suggest that toxin-mediated
T cell activation, which involves a large fraction of the human T cell repertoire, may be critical
in the pathogenesis of this disease.
T
oxic shock syndrome remains a serious disease charac-
terized by rapid onset of fever, rash, shock, and multi-
organ involvement (1-5) . Although the majority of cases are
associated with menstruation and tampon use, similar man-
ifestations have been increasingly recognizedin other settings
associatedwith focalStaphylococcus aureus infections(1-6). Exo-
proteins purified from S. aureus, particularly toxic shock syn-
drome toxin-1(TSST1), have been implicated in the patho-
genesis (7, 8), but the mechanism by which TSST1 results
in disease remains unclear.
Previous studies have demonstrated that S. aureus entero-
toxins, including TSST1, are powerful stimulators of T cell
proliferation in culture, in the presence of APCs bearing class
II major histocompatibility antigens (reviewed in reference
9). Recent work from our laboratories showed that stimula-
tion of human T cells by individual bacterial toxins is selec-
tive for cells expressing particular TCR0chain variable (VO)
gene segments (10, 11). Other variable elements (DO, J/3,
Vcx, Jot) of the TCR contribute little to the recognition of
these Vo-specific superantigens, as they do for conventional
antigens (9-11). Studies using a modified PCR to quantitate
V/3 expression in a population of T cell blasts demonstrated
that the majority of T cells stimulated by TSST1 in culture
specifically expressed Vf2. Based on these in vitro findings,
the present studies were initiated in patients with toxic shock
syndrome.
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Materials and Methods
Patients.
￿
Eight patients were referred for study by their private
physicians or through the Colorado Department of Public Health
(Pam Shillam, Epidemiology group), and all met the definition for
severe toxic shock syndrome (3, 4). Major criteria (all required)
for the diagnosis include fever(38.8°C), rash (diffuse erythema-
tous rash evolving to desquamation), and hypotension (systolic blood
pressure <90 mmHg for adults and/or orthostatic syncope or diz-
ziness). Minor criteria (three required) for the definition include
diarrhea and/or vomiting, muscular involvement, mucous mem-
brane hyperemia, decreased renalfunction or pyuria, elevated liver
enzymes, platelet count <100,000/mm3, and disorientation or al-
tered stateof consciousness. Disease in all patients appeared to be
related to a focus of S. aureus infection.
Stimulation andAnalysisofPeripheralBlood T Cells.
￿
PBMC were
isolated from heparinized blood, and to increase the production
offunctionalTCR mRNA, T cells were stimulatedwith anti-CD3
antibody and IIr2 (10, 11). The cells were then used for either im-
munofluorescence staining or quickly frozen in liquid nitrogen for
subsequent RNA extraction. Indirect immunofluorescence was per-
formed as described using mAbs directed to CD4, CD8, and to
epitopes on TCRs bearing V05, Va6, V08, and V/312 (10).
PCR and Quantitation ofAmplified Products.
￿
Total RNA pre-
pared from stimulatedcells was used for the synthesis offirst strand
cDNA as described (10, 11). For each PCR, oligonucleotide primers
included a V/ispecific oligomer and an oligomer from the down-
stream (3 chain constant region (CO primer) as one pair, and two
oligomers from the Cu region as the other pair. The sequences
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￿
Autoradiograms of TCR transcripts amplified by PCR .
T cells from Patient 1 (P) and control individual (C) were stimulated
with anti-CD3 antibody and 11,2 before extraction of RNA and
generation of cDNA . Each reaction contained specific oligonucleotide
primers to expand the particular VS gene segment indicated (170-220
bp), as well as a Cu gene segment (-600 bp) .
of the specific primersused and details of the PCR have been pub-
lished (11) . Amplificationwasperformedwith -25 cycles, chosen
to ensure that the amount ofproduct synthesized was proportional
to theamount ofV(3mRNA in the original preparation . Forquan-
titation of amplified products, 12P end-labeled 3' primers (-5 x
105 cpm each) were added to the reactions. The amplified prod-
ucts were separated on 2% agarose gels, dried, and analyzed with
an Ambis Radioanalytic Imaging System (Ambis Systems, San
Diego, CA).
Results and Discussion
T cells from patients and control individuals were stimu-
lated in culture with anti-CD3 antibody and 11,2 . Using
cDNA generated from T cell blastRNA and a quantitative
PCR, TCRgene segments encoding V02, V05 (5.2 and5.3),
Controls (n = 7)
(mean ± SE) 0 .09 ± 0.01
Peripheral blood was drawn from patients 3-14 d after the onset of symptoms .
t Quantitation of the amount of labeled primer incorporated into the V(3 and Ca bands (see Fig. 1) allowed for calculation of the ratios
presented (11) .
S Primers specific for a sequence common to V/35.2 and 5.3 or V08.1 and 8.2 were used (11) .
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V08 (8.1 and 8.2), andV012 were amplifiedandquantitated .
To control for the amount of TCR cDNA in the reaction
mixture, aCa gene segment was also amplified in each reac-
tion . Fig. 1 showsresults with T cells from one patient and
a concomitantly studied normal individual. A striking in-
crease in amplifiedV02DNA is apparent in the patient com-
pared with control, whereas little difference is observed in
Ca or otherVa products . The data in Table 1 are expressed
as a ratio of V/3DNA to Ca DNA amplified in the same
reaction . Although all o£ the controls had V02/Ca ratios
less than or equal to 0.10, initial samples from 5 of the 8
patients had ratios greater than 0.17 (p = 0.03 by Fisher's
exact test) with one, for Patient 1, as high as 0.78 . In con-
trast to V02, none of the otherVO/Cu ratios were increased
more than 2 SD abovecontrol values, indicating the selective
nature of V/32 expansion in toxic shock syndrome.
T cells isolated from patients and controls were also ana-
lyzed for subset alterations by indirect immunofluorescence
and cytofluorographic analysis. No consistent alterations in
the percentage of CD4* andCD8+ T cells were noted even
in patients with markedly elevated V02levels . For example,
the percentages of CD4+ and CD8+ cells, respectively, were
57 and 41 for Patient 1, 31 and 62 for Patient 2, and 78 and
22 for Patient 6 . These data are consistent with previous studies
demonstrating thatS. aureus enterotoxins stimulateboth CD4
and CD8 T cell populations in vitro (10) . Cells from 7 of
the 8 patients were also stained for the expression of Vf5,
V06, V08, andVf12 . Values outsidethenormal rangewere
not observed for these nonV02T cell subsets . Mean percent
(± SE) values for patients vs . controls (n = 12) were : V05,
2.4 ± 0.25 vs. 3.1 ± 0.30; V08, 4.3 ± 0.63 vs. 3.7 ± 0.50 ;
V06, 3.0 ± 0.46 vs . 3.4 ± 0.41; and V012, 1.6 ± 0.14 vs .
1.5 ± 0.09.
0.05±0.01 0.025±0.01 0.03±0.01
Table 1.
Patients'
V,B Expression in Peripheral Blood T Cells from
Source of S. aureus infection
Patients with
V02
Toxic Shock Syndrome
V(3/Ca
V05S
ratio$
V08S V012
1 Vagina, menstruation-related 0.78 0.07 0 .03 0 .02
2 Vagina, menstruation-related 0.25 0.02 0.01 0.03
3 Sinus 0.18 0.03 0.03 0.03
4 Vagina, menstruation-related 0.18 0.04 0.03 0.01
5 Vagina, post-surgical 0.11 0.04 0.04 0.01
6 Buttocks abscess 0 .46 0.04 0.03 0.01
7 Peritonsillar cellulitis 0.08 0.04 0.04 0.01
8 Vagina, menstruation-related 0.05 0.04 0.04 0.01U
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Figure 2 .
￿
Longitudinal changes in T cell repertoire in two patients
studied serially after toxic shock syndrome. Vf2/Ca (N), VS5/Ca
(A), V08/Ca (p), and V,612/Ca (A) ratios are presented for Pa-
tient 1 (top graph) and Patient 2 (bottom graph) in relation to the
number of days after the acute onset of symptoms. Normal values
(mean ± SE) are indicated by the symbols in the right of each
graph .
There is currently no mAb specific for human T cells ex-
pressing V)32, and therefore no direct method to quantitate
the percentage of these cells in peripheral blood. However,
based on those VOs against which specific mAbs are avail-
able, V#/Cot values obtained with thePCR can be converted
to the percentage ofT cells expressing the respective Vii (11) .
PCR data in this study suggest that Va2+ T cells in normal
individuals are -10% of the peripheral blood T cell popula-
tion . In contrast, peak values for patients 1 and 2 were -70%
and 30%, respectively, emphasizing the striking stimulation
occurring in some patients .
Serial samples were obtained from two patients to examine
longitudinal changes in T cell subsets after the acute disease.
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Fig. 2 shows that V02+ T cell percentages in these patients
returned nearly to normal by 45-60 d after the acute episode.
The fact that levels do normalize indicates that the increase
in V,Q2+ T cells occurs after the onset of toxic shock syn-
drome and is not a factor influencing susceptibility . These
serial studies also emphasize the relative lack of fluctuation
over time in T cell subsets expressing other Vf segments,
an observation alsomade in studies of normal individuals (10) .
Three of the eight patients studied did not demonstrate
elevated V02 levels. Our initial hypothesis was that disease
in these patients was caused by a S. aureus toxin different than
TSST1, and that other sets of T cells would be expanded
in a V(3specific fashion. We therefore measured a much larger
proportion of theT cell repertoire in these patients and con-
trols using 22 different oligonucleotide Vii-specific primers
(11) and quantitative PCR. Despite accounting for nearly70%
of theT cell repertoire, selective expansion of another T cell
subset could not be demonstrated (data not shown) . It is still
possible that an expanded subset was not included in this
analysis . However, we believe it is more likely that selective
Vila expansion was not reflected in the peripheral blood of
some patients because ofthe timing ofblood sampling. Studies
in rodents after immunization have indicated that antigen-
specific T cells are sequestered in lymphoid tissues (the site
ofantigen activation) where they are activated and expanded
in numbers before emigrating into the recirculating pool (12,
13) . It is interesting that two ofthe three patients with normal
V02+ T cell levels were studied within 3 d of the onset of
symptoms, whereas the highest Va2+ T cell percentages
were observed -10-14 d after onset of disease.
It is not entirely clear as to how a toxin such as TSST1
interacts with the host to produce the diverse manifestations
oftoxic shock syndrome . There is little evidence that TSST1
directly mediates the decreased vasomotor tone and increased
capillary leakage that results in shock, and humoral medi-
ators such as ILA and especially TNF have been implicated
(14, 15) . These cytokines can be shown to be released in cul-
tures ofmononuclear cells or macrophages after the addition
ofTSST1 or other S. aureus enterotoxins (reviewed in refer-
ences 9 and 14) . Recent studies in mice have also indicated
that the toxicity of S. aureus enterotoxin B is dependent on
the presence of T cells (16) . In support of a critical role for
T cells in the human disease, the data presented here indicate
that during toxic shock syndromeT cell stimulation occurs
on a scale not observed in response to conventional antigens
(9-11) . These activated T cells are likely to be releasing large
quantities of lymphokines such as IL-2, IFN-,y and lym-
photoxin (TNF-(3), all of which could be involved in the in-
duction of shock (15, 17, 18) .
We thank Pam Shillam (Colorado Department ofPublic Health), Drs. Stanley Deresinski (Palo Alto, CA),
Richard Abrams (Denver, CO), and Judith Anderson and Charles Chesley (Greeley, CO) for referring
patients for study, and Marjorie Greiner for help in preparation of the manuscript .
This work was supported in part by grants AI-28495, AI-17134, AI-22295, CA-42046, and AI-26490
from the National Institutes of Health . E . W. Gelfand is a Scholar of the Raymond and Beverley Sackler
Foundation .References
Address correspondence to Dr. Brian L. Kotzin, Division of Basic Sciences, National Jewish Center for
Immunology and Respiratory Medicine, 1400 Jackson St., Denver, CO 80206.
Received for publication 12 April 1990 and in revisedform 19 July 1990.
1. Todd, J.K., M. Fishaut, F. Kapral, and T Welch. 1978. Toxic
shock syndrome associated with phage-group 1-staphylococci.
Lancet. ii:1116.
2. Davis, J.P., P.J. Chesney, P.J. Wand, M. LaVenture, and the
Investigation and Laboratory Team. 1980. Toxic shock syn-
drome: epidemiologic features, recurrence, risk factors, and
prevention. N. Engl. J. Med. 303:1429.
3. Shands, K.N., G.P. Schmid, B.B. Dan, D.Blum, RJ. Guidotti,
N.T. Hargrett, R.L. Anderson, D.L. Hill, C.V. Broome,J.D.
Band, and D.W. Fraser. 1980. Toxic-shock syndrome in men-
struating women: association with tampon use and Staphy-
lococcal aureus andclinical features in 52 cases. N. Engl.J. Med.
303:1436.
4. Todd,J.K. 1988. Toxic shock syndrome. Clin. Microbiol. Rev.
1:432.
5. Chesney, P.J. 1989. Clinical aspects and spectrum of illness
of toxic shock syndrome: overview. Rev. Infect. Dis. II(Suppl.
1):81.
6. Reingold, A.L., NT Hargrett, B.B. Dan, K.N. Shands, BY
Strickland, andCV Broome. 1982.Nonmenstrual toxic shock
syndrome: a review of 130 cases. Ann. Int. Med. 96:871.
7. Bergdoll, M.S., B.A. Crass, R.F. Reiser, R.N. Robbins, and
J.P.Davis. 1981. Anew staphylococcal enterotoxin, enterotoxin
F, associated with toxic-shock-syndrome Staphylococcus aureus
isolates. Lancet. i:1017.
8. Schlievert, P.M., K.N. Shands, B.B. Dan, G.P. Schmid, and
R.D. Nishimura. 1981. Identification and characterization of
an exotoxin from Staphylococcus aureus associated with toxic
shock syndrome. J. Infect. Dis. 143:509.
9. Marrack, P., and J. Kappler. 1990. The staphylococcal en-
984
￿
T Cells in Toxic Shock Syndrome
terotoxins and their relatives. Science (Wash. DC). 248:705.
10. Kappler,J., B.L. Kotzin, L.Herron, E.W. Gelfand, R.D.Bigler,
A. Boylston, S. Carrel, D.N. Posnett, Y Choi, and P. Mar-
rack. 1989. Vl3-specific stimulation of human T cells by
staphylococcal toxins. Science (Wash. DC). 244:811.
11 . Choi, Y, B.L . Kotzin, L. Herron, J. Callahan, P. Marrack,
andJ. Kappler. 1989. Interaction of S. aureus toxin superan-
tigens with humanTcells.Proc Nad. Acad. Sci. USA. 86:8941.
12. Sprent, J., J.F.A.P. Miller, and G.F. Mitchell.. 1971. Antigen-
induced selective recruitment ofcirculating lymphocytes. Cell.
Immunol. 2:171.
13 . Wilson, D.B., A. Marshak, andJ.C. Howard. 1976. Specific
positive and negative selection of rat lymphocytes reactive to
strong histocompatibility antigens: activation with alloantigens
in vitro and in vivo. J. Immunol. 116:1030.
14. Parsonnet, J. 1989. Mediatorsin thepathogenesis oftoxic shock
syndrome: overview. Rev. Infect. Dis. II(Suppl. 1):S263.
15 . Beutler, B., andA.Cerami. 1987. Cachectin: more than a tumor
necrosis factor. N. Engl. J. Med. 316:379.
16 . Marrack, P., M. Blackman, E. Kushnir, andJ. Kappler. 1990.
The toxicity of staphylococcal enterotoxin Bin mice is medi-
ated by T cells. J. Expa Med. 171:455.
17. Nedwin, G.E., L.P. Svedersky, TS. Bringman, M.A. Palladino,
and D.V. Goedel. 1985 . Effect of interleukin 2, interferon-
gamma, and mitogens on the production of tumor necrosis
factors alpha and beta. J. Immunol. 135:2492.
18 . Gaynor,E.R., L. Vitek, L. Sticklin, S.P. Creekmore, M.E. Fer-
raro, J.X. Thomas, S.G. Fisher, and R.I. Fisher. 1988. The
hemodynamic effects of treatment with interleukin-2 and
lymphokine-activated killer cells. Ann. Int. Med. 109:953 .